Ironwood Pharmaceuticals, Inc.has announced Duzallo (lesinurad + allopurinol) was approved by the FDA as a once-daily oral treatment for hyperuricemia...
GrĂ¼nenthal announced that the European Commission has followed the positive opinion of the Committee for Medicinal Products for Human Use...
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation...